119 phenotypes from 20 alleles in 24 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Hnf4atm1(cre)Sdv/Hnf4a+ Myctm2.1Atp/Myctm2.1Atp involves: 129P2/OlaHsd * 129S/SvEv	normal liver/biliary system phenotype	J:137630
	normal mortality/aging	J:137630
Mycem1(IMPC)Kmpc/Myc+ C57BL/6NTac-Mycem1(IMPC)Kmpc/Kmpc	abnormal bone structure	J:211773
	decreased body length	J:211773
	decreased bone mineral content	J:211773
	decreased bone mineral density	J:211773
	decreased fluid intake	J:211773
	decreased prepulse inhibition	J:211773
	increased grip strength	J:211773
	increased startle reflex	J:211773
	short tibia	J:211773
Mycem1(IMPC)Kmpc/Mycem1(IMPC)Kmpc C57BL/6NTac-Mycem1(IMPC)Kmpc/Kmpc	preweaning lethality, complete penetrance	J:211773
Myctm1(Nmyc1)Fwa/Myctm1(Nmyc1)Fwa involves: 129P2/OlaHsd * C57BL/6	prenatal lethality, complete penetrance	J:62573
Myctm1.1(MYC)Gwbk/Myctm1.1(MYC)Gwbk involves: BALB/cJ * C57BL/6	no abnormal phenotype detected	J:189677
Myctm1.1(Nmyc1)Fwa/Myctm1.1(Nmyc1)Fwa involves: 129P2/OlaHsd * C57BL/6	abnormal skeletal muscle morphology	J:62573
	cyanosis	J:62573
	decreased birth body size	J:62573
	decreased birth weight	J:62573
	decreased body size	J:62573
	decreased body weight	J:62573
	normal immune system phenotype	J:62573
	neonatal lethality, incomplete penetrance	J:62573
Myctm1.1Cksn/Myctm1.1Cksn B6.129-Myctm1.1Cksn	normal immune system phenotype	J:170508
Myctm1.1Dlev/Myctm1.1Dlev involves: 129S4/SvJae * C57BL/6NCrl	no abnormal phenotype detected	J:186832
Myctm1.1Dmlo/Myctm1.1Dmlo involves: 129S2/SvPas * BALB/c * C57BL/6J * MF1	no abnormal phenotype detected	J:70610
Myctm1.1Itl/Myctm1.1Itl involves: 129S6/SvEvTac * C57BL/6NTac	abnormal enterocyte physiology	J:188927
	abnormal enterocyte proliferation	J:188927
	abnormal intestinal enteroendocrine cell morphology	J:188927
	abnormal intestinal goblet cell morphology	J:188927
	abnormal intestine morphology	J:188927
	abnormal large intestine crypts of Lieberkuhn morphology	J:188927
	abnormal response to injury	J:188927
	abnormal small intestine crypts of Lieberkuhn morphology	J:188927
	decreased Paneth cell number	J:188927
	decreased small intestinal villus size	J:188927
Myctm1Atp/Myc+ B6.129P2-Myctm1Atp	abnormal NK cell physiology	J:132730
	decreased memory T cell number	J:132730
	decreased T cell proliferation	J:132730
	normal immune system phenotype	J:132730
Myctm1Atp/Myc+ involves: 129P2/OlaHsd * FVB/N	decreased body size	J:73369
	decreased body weight	J:73369
	decreased bone marrow cell number	J:73369
	decreased fetal size	J:73369
	decreased fibroblast proliferation	J:73369
	decreased T cell proliferation	J:73369
	decreased white adipose tissue amount	J:73369
	lymph node hypoplasia	J:73369
	lymphoid hypoplasia	J:73369
	postnatal growth retardation	J:73369
	short tail	J:73369
	small lymphoid organs	J:73369
	spleen hypoplasia	J:73369
Myctm1Atp/Myctm1Atp involves: 129P2/OlaHsd	abnormal chorion morphology	J:137630
	abnormal placenta morphology	J:137630
	abnormal trophoblast layer morphology	J:137630
	normal cardiovascular system phenotype	J:137630
	placental labyrinth hypoplasia	J:137630
Myctm1Atp/Myctm1Atp involves: 129P2/OlaHsd * FVB/N	absent common myeloid progenitor cells	J:73369
	absent erythroid progenitor cell	J:73369
	absent fibroblast proliferation	J:73369
	decreased embryo size	J:73369
	embryonic lethality during organogenesis, complete penetrance	J:73369
	pale yolk sac	J:73369
Myctm1Atp/Myctm2.1Atp involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL	decreased body weight	J:73369
	decreased bone marrow cell number	J:73369
	decreased T cell proliferation	J:73369
	normal immune system phenotype	J:73369
	lymph node hypoplasia	J:73369
	spleen hypoplasia	J:73369
Myctm1Atp/Myctm2.1Atp Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N * SJL	normal immune system phenotype	J:73369
Myctm1Brd/Myc+ involves: 129S7/SvEvBrd * C57BL/6J	decreased litter size	J:4556
	reduced female fertility	J:4556
Myctm1Brd/Myctm1Brd involves: 129S7/SvEvBrd * C57BL/6J	abnormal embryo turning	J:4556
	distended pericardium	J:4556
	embryonic growth retardation	J:4556
	embryonic lethality during organogenesis, complete penetrance	J:4556
	enlarged heart	J:4556
	open neural tube	J:4556
Myctm1Jlc/Myctm1Jlc involves: 129S7/SvEvBrd	abnormal angiogenesis	J:79427
	abnormal dorsal aorta morphology	J:79427
	abnormal embryonic erythropoiesis	J:79427
	abnormal vascular development	J:79427
	abnormal vasculogenesis	J:79427
	abnormal visceral yolk sac morphology	J:79427
	decreased cell proliferation	J:79427
	decreased common myeloid progenitor cell number	J:79427
	decreased embryo size	J:79427
	decreased erythroid progenitor cell number	J:79427
	decreased tumor incidence	J:79427
Myctm1Lbox/Myc+ involves: 129S1/Sv * 129X1/SvJ * FVB/N	enlarged lymph nodes	J:97900
	enlarged spleen	J:97900
	increased B cell derived lymphoma incidence	J:97900
	increased B cell number	J:97900
	increased spleen weight	J:97900
	premature death	J:97900
Myctm1Lbox/Myctm1Lbox involves: 129S1/Sv * 129X1/SvJ * FVB/N	decreased T cell number	J:97900
	enlarged lymph nodes	J:97900
	enlarged spleen	J:97900
	increased B cell apoptosis	J:97900
	increased B cell derived lymphoma incidence	J:97900
	increased B cell number	J:97900
	increased B cell proliferation	J:97900
	increased spleen weight	J:97900
	premature death	J:97900
Myctm1Slek/Myctm1Slek involves: 129	no abnormal phenotype detected	J:131281
Myctm2.1Atp/Myc+ involves: 129P2/OlaHsd * C57BL/6 * SJL	decreased body weight	J:73369
	decreased T cell proliferation	J:73369
Myctm2.1Atp/Myctm2.1Atp Edil3Tg(Sox2-cre)1Amc/Edil3+ involves: 129P2/OlaHsd * C57BL/6 * CBA	abnormal common myeloid progenitor cell morphology	J:137630
	abnormal proerythroblast morphology	J:137630
	normal cardiovascular system phenotype	J:137630
	decreased embryo size	J:137630
	decreased erythroid progenitor cell number	J:137630
	embryonic lethality during organogenesis, complete penetrance	J:137630
	impaired hematopoiesis	J:137630
	liver hypoplasia	J:137630
	pale yolk sac	J:137630
Myctm2.1Atp/Myctm2.1Atp Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N * SJL	absent fibroblast proliferation	J:73369
	normal immune system phenotype	J:73369
Myctm2.1Atp/Myctm2.1Atp Tg(Pdx1-cre)1Herr/0 involves: 129P2/OlaHsd * C57BL/6J * CBA/J	abnormal enzyme/coenzyme activity	J:146087
	abnormal pancreas development	J:146087
	abnormal pancreas morphology	J:146087
	abnormal pancreas size	J:146087
	abnormal pancreatic acinar cell morphology	J:146087
	abnormal pancreatic acinus morphology	J:146087
	abnormal pancreatic duct morphology	J:146087
	absent pancreatic acinar cells	J:146087
	decreased pancreas weight	J:146087
	normal endocrine/exocrine gland phenotype	J:146087
	pancreas hypoplasia	J:146087
Myctm2.1Atp/Myctm2.1Atp Tg(Tek-cre)1Rwng/0 involves: 129P2/OlaHsd * FVB/N	abnormal hematopoietic system morphology/development	J:137630
	abnormal liver morphology	J:137630
	normal cardiovascular system phenotype	J:137630
	embryonic lethality during organogenesis, complete penetrance	J:137630
	liver hypoplasia	J:137630
	pale yolk sac	J:137630
	small liver	J:137630
Myctm2Dmlo/Myctm2Dmlo involves: 129S2/SvPas * BALB/c * C57BL/6J * MF1	no abnormal phenotype detected	J:70610
Myctm2Fwa/Myc+ H2az2Tg(Wnt1-cre)11Rth/H2az2+ involves: 129S6/SvEvTac * C57BL/6 * CBA	belly spot	J:121871
Myctm2Fwa/Myctm2Fwa involves: 129S6/SvEvTac	no abnormal phenotype detected	J:67222
Myctm2Fwa/Myctm2Fwa Cd19tm1(cre)Cgn/Cd19+ involves: 129P2/OlaHsd * 129S6/SvEvTac	decreased B cell proliferation	J:67222
Myctm2Fwa/Myctm2Fwa H2az2Tg(Wnt1-cre)11Rth/H2az2+ involves: 129S6/SvEvTac * C57BL/6 * CBA	abnormal auditory brainstem response	J:121871
	abnormal frontal bone morphology	J:121871
	abnormal malleus morphology	J:121871
	abnormal middle ear ossicle morphology	J:121871
	abnormal parietal bone morphology	J:121871
	absent pinna reflex	J:121871
	conductive hearing impairment	J:121871
	decreased body size	J:121871
	decreased body weight	J:121871
	short malleus manubrium	J:121871
	short nasal bone	J:121871
	short snout	J:121871
	small cranium	J:121871
	small malleus	J:121871
	small nasal bone	J:121871
	variable body spotting	J:121871
Myctm3(Tcrb)Fwa/Myc+ involves: 129	abnormal T cell receptor beta chain V(D)J recombination	J:131995
Myctm4.1Fwa/Myctm4.1Fwa involves: 129S6/SvEvTac	induced chromosome breakage	J:150339
Myctm37Mnz/Myc+ involves: C57BL/6	induced chromosome breakage	J:145691
Myctm39Mnz/Myc+ involves: C57BL/6	spontaneous chromosome breakage	J:145691